Clark Estates Inc’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-845,000
Closed -$11.8M 93
2026
Q1
$11.8M Sell
845,000
-43,880
-5% -$591K 2.84% 12
2025
Q4
$9.98M Buy
888,880
+105,000
+13% +$1.2M 2.42% 11
2025
Q3
$9.06M Buy
783,880
+290,000
+59% +$3.4M 2.07% 14
2025
Q2
$6.05M Hold
493,880
1.36% 15
2025
Q1
$7.08M Buy
+493,880
New +$7.71M 1.5% 14

Other funds holding AVNS

Clark Estates Inc's AVNS Position: Q2 2026 in Review

Clark Estates Inc sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 845,000 shares — an estimated $11.8M sold.

Clark Estates Inc first reported a position in AVNS in Q1 2025 and held it in 5 quarters. The position peaked at $11.8M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Clark Estates Inc reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Clark Estates Inc sold 845,000 Avanos Medical shares in Q2 2026, an estimated $11.8M.
  • Clark Estates Inc first reported a position in Avanos Medical in Q1 2025 and held it in 5 quarters.
  • Clark Estates Inc's Avanos Medical position peaked at $11.8M in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.